Kathy Giusti, M.B.A. ’85, founder and CEO of the Multiple Myeloma Research Foundation (MMRF), will address this year's imminent graduates of Harvard Business School as Class Day speaker. She founded the MMRF in 1998 after being diagnosed with multiple myeloma. This spring, Time magazine named her one of the "100 most influential people" in the world. Multiple myeloma is a cancer of plasma cells—white blood cells that produce antibodies; it affects from one to four people per 100,000 and constitutes 1 percent of all cancers. Before starting MMRF, Giusti was an executive with pharmaceutical companies, and she has sought to encourage the development of drugs to treat the disease using a business model, rather than an academic model, of drug development. The MMRF is the world's top funder of myeloma research: it has raised more than $165 million to fund research.
Multiple myeloma research crusader Kathy Giusti to speak at HBS Class Day
The founder of the Multiple Myeloma Research Foundation will speak at Harvard Business School Class Day.
Kathy Giusti | Photograph courtesy of the Multiple Myeloma Research Foundation
You might also like
The award-winning international journalist has served as interim curator since 2025.
The organization said its amicus brief had not been reviewed internally.
The longtime administrator, who retired from the post in 2018, returns as the College reorganizes.
Most popular
Explore More From Current Issue
In her memoir All That's Unseen, Emilee Hackney explores religion, friendship, and home.
Author and Harvard Divinity School writer-in-residence Terry Tempest Williams finds beauty in the world around us.
Growing liver implants, mapping the sense of smell, and journalism at risk